Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer-Reference-Cited by-同舟云学术

Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer

Published:2015-11 Issue:5 Volume:194 Page:1277-1284
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Smith Matthew R.¹,Rathkopf Dana E.²,Mulders Peter F.A.³,Carles Joan⁴,Van Poppel Hendrik⁵,Li Jinhui⁶,Kheoh Thian⁷,Griffin Thomas W.⁸,Molina Arturo⁹,Ryan Charles J.¹⁰

Affiliation:

1. Department of Genitourinary Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts

2. Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

3. Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands

4. Department of Oncology, Vall d’Hebron University Hospital, Barcelona, Spain

5. Department of Urology, University Hospitals of KU Leuven, Leuven, Belgium

6. Department of Biostatistics Oncology, Janssen Research & Development, Raritan, New Jersey

7. Department of Biostatistics and Programming, Janssen Research & Development, San Diego, California

8. Department of WC Clinical Oncology, Janssen Research & Development, Los Angeles, California

9. Department of Oncology, Janssen Research & Development, Los Angeles, California

10. Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. New treatment developments applied to elderly patients with advanced prostate cancer;Mukherji;Cancer Treat Rev,2013

3. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality;Scosyrev;Cancer,2012

4. Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology;Droz;Lancet Oncol,2014

5. Prostate cancer in the elderly patient;Fung;J Clin Oncol,2014

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study;Clinical Genitourinary Cancer;2024-08

2. Real-world treatment trends for patients with advanced prostate cancer and renal cell carcinoma and their cost—a survey in Japan;Japanese Journal of Clinical Oncology;2024-06-07

3. Systemtherapie des Prostatakarzinoms im hohen Alter;Die Onkologie;2024-01-26

4. Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort;Journal of Geriatric Oncology;2023-11

5. Adverse Events of Abiraterone Acetate vs Enzalutamide;Urology Practice;2023-07